Targeting YAP in malignant pleural mesothelioma

Malignant mesothelioma is an aggressive cancer that is resistant to current therapy. The poor prognosis of mesothelioma has been associated with elevated Yes‐associated protein (YAP) activity. In this study, we evaluated the effect of targeting YAP in mesothelioma. First, we comprehensively studied...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Cell Mol Med
Autori principali: Zhang, Wen‐Qian, Dai, Yu‐Yuan, Hsu, Ping‐Chih, Wang, Hui, Cheng, Li, Yang, Yi‐Lin, Wang, Yu‐Cheng, Xu, Zhi‐Dong, Liu, Shu, Chan, Geraldine, Hu, Bin, Li, Hui, Jablons, David M., You, Liang
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Original Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5661117/
https://ncbi.nlm.nih.gov/pubmed/28470935
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jcmm.13182
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi